Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference15 articles.
1. Neoadjuvant chemotherapy for primary breast cancer: lessons learned and opportunities to optimize therapy;Esserman;Ann Surg Oncol,2004
2. Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer;Estevez;Clin Cancer Res,2004
3. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998
4. Interim analysis of a phase II trial of cyclophosphamide, epirubicin, 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma;Iwata;Breast Cancer,2005
5. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer:review and recommendations;Kaufmann;J Clin Oncol,2003
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Correlations Between Molecular Subtypes and Pathologic Response Patterns of Breast Cancers After Neoadjuvant Chemotherapy;Annals of Surgical Oncology;2014-09-06
2. Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG;Breast Cancer;2014-02-27
3. An overview of the Japan Breast Cancer Research Group (JBCRG) activities;Breast Cancer;2013-03-15
4. Chemotherapy, Trastuzumab, and Pathological Complete Response: When Shall We Three Meet Again?;Journal of Clinical Oncology;2011-09-01
5. A histopathological study for evaluation of therapeutic effects of radiofrequency ablation in patients with breast cancer;Breast Cancer;2010-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3